BAFF inhibition can attenuate fibrosis in a bleomycin-induced mouse model SSc with reduction of fibrotic IL-6 producing Beffs, but not regulatory IL-10 producing Bregs (109). Here, TNFSF13B is linked to systemic sclerosis.